- Published at
- by finance.yahoo.com
positive
positive
Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Cytokinetics, Incorporated (NASDAQ:CYTK) on June 4 and set a price target of $107.00. JPMorgan analyst Tessa Romero also gave Cytokinetics, Incorporated (NASDAQ:CYTK) a rating update on June […]